PTC Therapeutics, Inc.
US ˙ NasdaqGS ˙ US69366J2006

SecurityPTCT / PTC Therapeutics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership1,364,768 shares
Latest Disclosed Value $ 92,981,644
UBS Group AG ownership in PTCT / PTC Therapeutics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,364,768 shares of PTC Therapeutics, Inc. (US:PTCT) valued at $92,981,644 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 964,658 shares of PTC Therapeutics, Inc.. This represents a change in shares of 41.48% during the quarter. The current value of the position is $93,732,266 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (PTCT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PTCT / PTC Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F PTC THERAPEUTICS COM 69366J200 1,364,768 400,110 41.48 92,982 26.89 0.0026
2026-01-29 2025-12-31 13F PTC THERAPEUTICS COM 69366J200 964,658 512,449 113.32 73,275 164.04 0.0119
2025-11-13 2025-09-30 13F PTC THERAPEUTICS COM 69366J200 452,209 -126,741 -21.89 27,752 -1.85 0.0043
2025-08-14 2025-06-30 13F PTC THERAPEUTICS COM 69366J200 578,950 -690,697 -54.40 28,276 -56.30 0.0049
2025-05-13 2025-03-31 13F PTC THERAPEUTICS COM 69366J200 1,269,647 198,596 18.54 64,701 33.83 0.0119
2025-02-14 2024-12-31 13F PTC THERAPEUTICS COM 69366J200 1,071,051 905,980 548.84 48,347 689.47 0.0089
2024-11-14 2024-09-30 13F PTC THERAPEUTICS COM 69366J200 165,071 28,310 20.70 6,124 46.44 0.0013
2024-08-14 2024-06-30 13F PTC THERAPEUTICS COM 69366J200 136,761 -88,699 -39.34 4,182 -36.23 0.0010
2024-05-13 2024-03-31 13F PTC THERAPEUTICS COM 69366J200 225,460 -63,288 -21.92 6,559 -17.58 0.0016
2024-02-09 2023-12-31 13F PTC THERAPEUTICS COM 69366J200 288,748 210,883 270.83 7,958 356.25 0.0024
2023-11-09 2023-09-30 13F PTC THERAPEUTICS COM 69366J200 77,865 -14,186 -15.41 1,745 -53.41 0.0006
2023-08-11 2023-06-30 13F PTC THERAPEUTICS COM 69366J200 92,051 15,229 19.82 3,744 0.59 0.0013
2023-05-12 2023-03-31 13F PTC THERAPEUTICS COM 69366J200 76,822 -32,046 -29.44 3,721 -10.45 0.0014
2023-02-08 2022-12-31 13F PTC THERAPEUTICS COM 69366J200 108,868 78,107 253.92 4,155 169.11 0.0016
2022-11-10 2022-09-30 13F PTC THERAPEUTICS COM 69366J200 30,761 -27,031 -46.77 1,544 -33.30 0.0007
2022-08-10 2022-06-30 13F PTC THERAPEUTICS COM 69366J200 57,792 -84,177 -59.29 2,315 -56.29 0.0010
2022-05-16 2022-03-31 13F PTC THERAPEUTICS COM 69366J200 141,969 12,297 9.48 5,296 2.56 0.0018
2022-02-14 2021-12-31 13F PTC THERAPEUTICS COM 69366J200 129,672 66,850 106.41 5,164 120.87 0.0015
2021-11-15 2021-09-30 13F PTC THERAPEUTICS COM 69366J200 62,822 62,729 67,450.54 2,338 58,350.00 0.0007
2021-08-13 2021-06-30 13F PTC THERAPEUTICS COM 69366J200 93 -32,879 -99.72 4 -99.74 0.0000
2021-05-12 2021-03-31 13F PTC THERAPEUTICS COM 69366J200 32,972 32,588 8,486.46 1,562 6,691.30 0.0005
2021-02-11 2020-12-31 13F PTC THERAPEUTICS COM 69366J200 384 90 30.61 23 64.29 0.0000
2020-11-12 2020-09-30 13F PTC THERAPEUTICS COM 69366J200 294 -4,769 -94.19 14 -94.55 0.0000
2020-07-31 2020-06-30 13F PTC THERAPEUTICS COM 69366J200 5,063 -66,826 -92.96 257 -91.99 0.0001
2020-05-01 2020-03-31 13F PTC THERAPEUTICS COM 69366J200 71,889 14,140 24.49 3,207 15.61 0.0015
2020-02-14 2019-12-31 13F PTC THERAPEUTICS COM 69366J200 57,749 -28,857 -33.32 2,774 -5.29 0.0010
2019-11-14 2019-09-30 13F PTC THERAPEUTICS COM 69366J200 86,606 77,339 834.56 2,929 602.40 0.0011
2019-08-14 2019-06-30 13F PTC THERAPEUTICS COM 69366J200 9,267 411 4.64 417 24.85 0.0002
2019-05-14 2019-03-31 13F PTC THERAPEUTICS COM 69366J200 8,856 -74,541 -89.38 334 -88.33 0.0001
2019-02-14 2018-12-31 13F PTC THERAPEUTICS COM 69366J200 83,397 53,298 177.08 2,862 102.26 0.0013
2018-11-14 2018-09-30 13F PTC THERAPEUTICS COM 69366J200 30,099 18,088 150.60 1,415 249.38 0.0006
2018-08-14 2018-06-30 13F PTC THERAPEUTICS COM 69366J200 12,011 1,713 16.63 405 45.16 0.0002
2018-05-15 2018-03-31 13F PTC THERAPEUTICS COM 69366J200 10,298 -65,565 -86.43 279 -77.96 0.0001
2018-02-14 2017-12-31 13F PTC THERAPEUTICS COM 69366J200 75,863 12,150 19.07 1,266 -0.71 0.0005
2017-11-14 2017-09-30 13F PTC THERAPEUTICS COM 69366J200 63,713 36,277 132.22 1,275 153.48 0.0006
2017-11-14 2017-06-30 13F/A-1 PTC THERAPEUTICS COM 69366J200 27,436 3,123 12.84 503 110.46 0.0003
2017-08-14 2017-06-30 13F PTC THERAPEUTICS COM 69366J200 27,436 503
2017-11-14 2017-03-31 13F/A-1 PTC THERAPEUTICS COM 69366J200 24,313 17,968 283.18 239 246.38 0.0001
2017-05-12 2017-03-31 13F PTC THERAPEUTICS COM 69366J200 24,313 17,968 239
2017-02-14 2016-12-31 13F PTC THERAPEUTICS COM 69366J200 6,345 -2,765 -30.35 69 -46.09 0.0000
2016-11-14 2016-09-30 13F PTC THERAPEUTICS COM 69366J200 9,110 592 6.95 128 113.33 0.0001
2016-08-12 2016-06-30 13F PTC THERAPEUTICS COM 69366J200 8,518 -37,487 -81.48 60 -79.73 0.0000
2016-05-12 2016-03-31 13F PTC THERAPEUTICS COM 69366J200 46,005 19,774 75.38 296 -65.18 0.0002
2016-02-16 2015-12-31 13F PTC THERAPEUTICS COM 69366J200 26,231 16,531 170.42 850 228.19 0.0006
2015-11-13 2015-09-30 13F PTC THERAPEUTICS COM 69366J200 9,700 8,769 941.89 259 475.56 0.0002
2015-08-14 2015-06-30 13F PTC THERAPEUTICS COM 69366J200 931 21 2.31 45 -18.18 0.0000
2015-05-14 2015-03-31 13F PTC THERAPEUTICS COM 69366J200 910 -555 -37.88 55 -27.63 0.0000
2015-02-17 2014-12-31 13F PTC THERAPEUTICS COM 69366J200 1,465 1,465 76 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-12 2021-03-31 13F PTC THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F PTC THERAPEUTICS COM Call 33,800 2,063 n/a n/a n/a
2017-11-14 2017-06-30 13F/A PTC THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-03-31 13F/A PTC THERAPEUTICS COM Call 159,200 1,567 n/a n/a n/a
2017-05-12 2017-03-31 13F PTC THERAPEUTICS COM Call 159,200 1,567 n/a n/a n/a
2015-08-14 2015-06-30 13F PTC THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-14 2015-03-31 13F PTC THERAPEUTICS COM Call 5,000 304 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-05-12 2016-03-31 13F PTC THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F PTC THERAPEUTICS COM Put 296,100 9,594 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.